Page 27 - Pharma Industry

Pharma, chemical stocks lead under lockdown, Aurobindo is top performer

Within BSE-500, 79% stocks gave positive returns in two months of lockdown

Pharma export growth in FY20 down to single digit due to Covid: Pharmexcil

Export growth started declining in February and turned negative in March, at -23.24 per cent

Mumbai docs try Biocon and Roche's biologic drugs on critical Covid cases

Two repurposed drugs for rheumatoid arthritis and psoriasis are being tried on over 100 patients in Mumbai

Covid-19 lockdown: Domestic pharma growth takes hit as stock piles up

Inventory days have gone up from 31 days as on March 22 to 41 days as on April 22

Pharma traders seek IT rule exemption as retailers pay stockists in cash

They fear scrutiny by tax authorities at a later date, assure that the relaxation will not be misused

Taking a nap, playing ludo: Gujarat pharma hub hit by near-zero exports

Companies finding it tough to source raw materials amid the lockdown

Aurobindo Pharma faces class action suit in US for concealing facts

Aurobindo Pharma allegedly concealed facts about cancer-causing agent NDMA in type-2 diabetes drug metformin

Aurobindo Pharma's debt pain recedes after calling off deal with Sandoz

Aurobindo was scheduled to acquire the portfolio with an upfront purchase price of $900 million in cash

Aurobindo terminates $900-million Sandoz product acquistion deal

A mutual decision to cancel the agreement was taken as approval from US Federal Trade Commission was not obtained within anticipated timelines

India may soon ease some drug export curbs under US pressure: Report

Imports from India accounted for 24% of medicines and 31% of medicine ingredients to the United States in 2018, according to the US Food and Drug Administration

Pharma group seeks relaxation of export restrictions for committed orders

Bhaskar explained that some of the orders for institutional supplies mandate the supply of all items committed in their contracts.

Coronavirus impact: Firms stare at prospect of airlifting raw materials

Pharma industry officials said the aerial route was the best option available to companies right now, given the congestion at Chinese ports.

Coronavirus outbreak: Don't panic over supplies, says pharma industry

Sun Pharma's Dilip Shanghvi said the industry and government were working closely to reduce dependence on one country

Indian pharma industry needs to adopt digital technologies, says EY report

India is the largest provider of generic drugs globally, fulfilling about 40 per cent of the generics demand in the US and roughly 25 per cent of all medicines in UK

Pharma industry poised to beat FY19 exports despite strict US regulations

April-December exports rise 11.5%; estimates peg FY20 numbers at $22 billion

Pharma companies can draw $30 bn revenue from US market by tapping 10 drugs

Despite having good demand from across the markets, primarily due to lower prices and easy availability, India controls only 2.4 per cent of global pharma exports

Tipping point: Should you bet on the revival of pharmaceutical funds?

Whenever the domestic economy is not doing well, smart money shifts to export-oriented sectors like pharma

Pharma industry considering 'ethics inspectors' to ensure better compliance

Pharma players to meet DoP to discuss suggestions around implementing ethical marketing practices code

Legacy pharma brands spin gold for GSK, Pfizer; keep newcomers off the turf

Repositioning an old brand helps expand the footprint, say analysts

In a booster dose, pharma industry gets 'green' signal in New Year

Drug makers allowed to tweak product mix or quantity without fresh environment clearance until effluent load is same